Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis

被引:16
作者
Roth, Beat [1 ,5 ]
Jayaratna, Isuru [1 ]
Sundi, Debasish [1 ]
Cheng, Tiewei [1 ,3 ,4 ]
Melquist, Jonathan [1 ]
Choi, Woonyoung [1 ]
Porten, Sima [1 ]
Nitti, Giovanni
Navai, Neema [1 ]
Wszolek, Matthew [1 ,6 ]
Guo, Charles [2 ]
Czerniak, Bogdan [2 ]
McConkey, David [1 ]
Dinney, Colin [1 ]
机构
[1] MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[2] MD Anderson Canc Ctr, Dept Pathol, Houston, TX USA
[3] Univ Texas Houston, Grad Sch Biomed Sci, Program Expt Therapeut, Houston, TX USA
[4] Univ Texas Houston, Grad Sch Biomed Sci, Programs Canc Biol, Houston, TX USA
[5] Univ Hosp Bern, Dept Urol, Bern, Switzerland
[6] Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA USA
关键词
SNAIL; metastasis; circulating tumor cells; orthotopic xenografts; bladder cancer; CIRCULATING TUMOR-CELLS; RADICAL CYSTECTOMY; EXPRESSION; CARCINOMA; IMPLANTATION; PROSTATE; GROWTH; MIGRATION; DISPLAY; PROTEIN;
D O I
10.18632/oncotarget.11009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial-to-mesenchymal transition (EMT) has been implicated in the progression of bladder cancer. To study its contribution to bladder cancer metastasis, we established new xenograft models derived from human bladder cancer cell lines utilizing an orthotopic "recycling" technique that allowed us to isolate and examine the primary tumor and its corresponding circulating tumor cells (CTC's) and metastatic lesions. Using whole genome mRNA expression profiling, we found that a reversible epithelial-to-mesenchymal transition (EMT) characterized by TGF beta pathway activation and SNAIL expression was associated with the accumulation of CTCs. Finally, we observed that conditional silencing of SNAIL completely blocked CTC production and regional/distant metastasis. Using this unique bladder cancer xenograft model, we conclude that metastasis is dependent on a reversible EMT mediated by SNAIL.
引用
收藏
页码:34205 / 34222
页数:18
相关论文
共 59 条
[1]   miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy [J].
Adam, Liana ;
Zhong, Meng ;
Choi, Woonyoung ;
Qi, Wei ;
Nicoloso, Milena ;
Arora, Ameeta ;
Calin, George ;
Wang, Hua ;
Siefker-Radtke, Arlene ;
McConkey, David ;
Bar-Eli, Menashe ;
Dinney, Colin .
CLINICAL CANCER RESEARCH, 2009, 15 (16) :5060-5072
[2]  
[Anonymous], 2016, ALTERNAT MED
[3]   Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers [J].
Armstrong, Andrew J. ;
Marengo, Matthew S. ;
Oltean, Sebastian ;
Kemeny, Gabor ;
Bitting, Rhonda L. ;
Turnbull, James D. ;
Herold, Christina I. ;
Marcom, Paul K. ;
George, Daniel J. ;
Garcia-Blanco, Mariano A. .
MOLECULAR CANCER RESEARCH, 2011, 9 (08) :997-1007
[4]   Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors [J].
Baumgart, Egbert ;
Cohen, Michael S. ;
Neto, Brasil Silva ;
Jacobs, Micah A. ;
Wotkowicz, Chad ;
Rieger-Christ, Kimberly M. ;
Biolo, Andreia ;
Zeheb, Ron ;
Loda, Massimo ;
Libertino, John A. ;
Summerhayes, Ian C. .
CLINICAL CANCER RESEARCH, 2007, 13 (06) :1685-1694
[5]   Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies [J].
Bettegowda, Chetan ;
Sausen, Mark ;
Leary, Rebecca J. ;
Kinde, Isaac ;
Wang, Yuxuan ;
Agrawal, Nishant ;
Bartlett, Bjarne R. ;
Wang, Hao ;
Luber, Brandon ;
Alani, Rhoda M. ;
Antonarakis, Emmanuel S. ;
Azad, Nilofer S. ;
Bardelli, Alberto ;
Brem, Henry ;
Cameron, John L. ;
Lee, Clarence C. ;
Fecher, Leslie A. ;
Gallia, Gary L. ;
Gibbs, Peter ;
Le, Dung ;
Giuntoli, Robert L. ;
Goggins, Michael ;
Hogarty, Michael D. ;
Holdhoff, Matthias ;
Hong, Seung-Mo ;
Jiao, Yuchen ;
Juhl, Hartmut H. ;
Kim, Jenny J. ;
Siravegna, Giulia ;
Laheru, Daniel A. ;
Lauricella, Calogero ;
Lim, Michael ;
Lipson, Evan J. ;
Marie, Suely Kazue Nagahashi ;
Netto, George J. ;
Oliner, Kelly S. ;
Olivi, Alessandro ;
Olsson, Louise ;
Riggins, Gregory J. ;
Sartore-Bianchi, Andrea ;
Schmidt, Kerstin ;
Shih, Ie-Ming ;
Oba-Shinjo, Sueli Mieko ;
Siena, Salvatore ;
Theodorescu, Dan ;
Tie, Jeanne ;
Harkins, Timothy T. ;
Veronese, Silvio ;
Wang, Tian-Li ;
Weingart, Jon D. .
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)
[6]   Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism [J].
Bhowmick, NA ;
Ghiassi, M ;
Bakin, A ;
Aakre, M ;
Lundquist, CA ;
Engel, ME ;
Arteaga, CL ;
Moses, HL .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (01) :27-36
[7]   EMT and MET in Metastasis: Where Are the Cancer Stem Cells? [J].
Brabletz, Thomas .
CANCER CELL, 2012, 22 (06) :699-701
[8]   Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor-2 [J].
Chaffer, Christine L. ;
Brennan, Janelle P. ;
Slavin, John L. ;
Blick, Tony ;
Thompson, Erik W. ;
Williams, Elizabeth D. .
CANCER RESEARCH, 2006, 66 (23) :11271-11278
[9]   Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity [J].
Chaffer, Christine L. ;
Marjanovic, Nemanja D. ;
Lee, Tony ;
Bell, George ;
Kleer, Celina G. ;
Reinhardt, Ferenc ;
D'Alessio, Ana C. ;
Young, Richard A. ;
Weinberg, Robert A. .
CELL, 2013, 154 (01) :61-74
[10]   A Perspective on Cancer Cell Metastasis [J].
Chaffer, Christine L. ;
Weinberg, Robert A. .
SCIENCE, 2011, 331 (6024) :1559-1564